Top 5 Promising Stocks To Buy For 2014

Merck (NYSE: MRK  ) is scheduled to release its quarterly earnings report tomorrow, and most investors expect the company to see continued reductions in its overall net income compared to year-ago levels. Yet the stock has performed quite well lately, suggesting that in the long run, Merck earnings could well return to their winning ways, helping to support a dividend yield that puts the drugmaker in the upper echelon of dividend stocks within the Dow Jones Industrials (DJINDICES: ^DJI  ) .

Like many of its drugmaker peers, Merck has struggled as major blockbuster products have gone off patent, forcing it to try to find replacement drugs to keep its overall sales and profit up. So far, Merck has only had mixed success in accomplishing that difficult task, but some promising prospects could help the company get past its patent-cliff woes and get back to strong growth. Let's take an early look at what's been happening with Merck over the past quarter and what we're likely to see in its quarterly report.

Top 5 Specialty Retail Companies To Invest In 2015: Antares Pharma Inc (ATRS)

Antares Pharma, Inc. (Antares) is a pharma company that focuses on self-injection pharmaceutical products and technologies and topical gel-based products. The Company�� subcutaneous and intramuscular injection technology platforms include Vibex disposable pressure-assisted auto injectors, Vision reusable needle-free injectors, and disposable multi-use pen injectors. In the injector area, it has licensed its reusable needle-free injection device for use with human growth hormone (hGH) to Teva, Ferring Pharmaceuticals BV (Ferring) and JCR Pharmaceuticals Co., Ltd. (JCR), with Teva and Ferring being its two primary customers. The Company has also licensed both disposable auto and pen injection devices to Teva for use in certain fields and territories and is engaged in product development activities for Teva utilizing these devices.

In the gel-based area, it received Food and Drug Administration (FDA) approval in December 2011 for its oxybutynin gel 3% product, Anturol, for the treatment of overactive bladder. Antares also has a licensing agreement with Watson Watson Pharmaceuticals, Inc. (Watson) under which Watson will commercialize its topical oxybutynin gel 3% product in the United States and Canada. Its gel portfolio also includes Elestrin (estradiol gel) in the United States for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. Antares has designed disposable, pressure assisted auto injector devices to address acute medical needs, such as allergic reactions, migraine headaches, acute pain, emesis and other daily therapies.

Pressure Assisted Injection Devices

The Company�� Pressure Assisted Injection Devices consists of three products: reusable needle-free injectors, disposable pressure assisted auto injectors and disposable pen injectors. Reusable needle-free injectors deliver precise medication doses through high-speed, pressurized liquid penetration of the skin without a needle. The injector employs a disposable pl! astic needle-free syringe, which offers liquid medication delivery through an opening that is approximately half the diameter of a standard, 30-gauge needle.

Disposable pressure assisted auto injectors is a technology of controlled pressure delivery of drugs into the body utilizing a spring power source. The Vibex is designed to provide fast subcutaneous or intramuscular injections of up to 0.5ml with minimal discomfort and improved convenience in conjunction with the enhanced safety of a shielded needle. Disposable pen injectors are needle-based devices designed to deliver multiple injections from multi-dose drug cartridges. The devices contain mechanisms that specify the dose to be delivered by defining the amount of movement by the stopper in the cartridge with each device actuation.

The Vision/Tjet has been sold for use in more than 30 countries to deliver either insulin or hGH. The product features a reusable, spring-based power source and disposable needle-free syringe, which acts as the pathway for the injectable drug through the skin and allows for viewing of the medication dose prior to injection. The product is also reusable, with each device designed to last for approximately 3,000 injections (or approximately two years) while the needle-free syringe, when used with insulin or hGH, is disposable after approximately one week when used by a single patient for injecting from multi-dose vials. The Vision/Tjet administers injectables by using a spring to push the active ingredient in solution or suspension through a micro-fine opening in the needle-free syringe. The opening is approximately half the diameter of a 30-gauge needle. The Vision/Tjet is primarily used in the United States, Europe, Asia and Japan.

Antares has designed disposable, pressure assisted auto injector devices to address acute medical needs, such as allergic reactions, migraine headaches, acute pain, emesis and other daily therapies. Its Vibex disposable product combines a low-energy, spr! ing-based! power source with a hidden needle, which delivers up to 0.5ml of the needed drug solution subcutaneously or intramuscularly. Antares is also developing a Vibex MTX auto injector for delivery of methotrexate for treatment of rheumatoid arthritis. The Company�� multi use, disposable pen injector complements its portfolio of single-use pressure assisted auto injector devices. The disposable pen injector device is designed to deliver drugs by injection through needles from multi- dose cartridges. The disposable pen is in the stage of development where devices are being used in clinical evaluations.

Transdermal Products

The Company�� ATD system penetrates the skin to deliver a variety of treatments. The gels consist of a hydro-alcoholic base, including a combination of permeation enhancers. Products being developed/ commercialized include Anturol, Elestrin and Nestragel. Elestrin is a transdermal estradiol gel for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. Its other injectable drugs that are presently self-administered and may be suitable for injection with its systems include therapies for the prevention of blood clots and treatments for multiple sclerosis, migraine headaches, inflammatory diseases, impotence, infertility, acquired immune deficiency symdrome (AIDS) and hepatitis.

The Company competes with Ypsomed AG, SHL Group AB, OwenMumford Ltd., West Pharmaceuticals, Becton Dickinson, Haselmeir GmbH, Elcam Medical, Vetter Pharma, Bioject Medical Technologies Inc., The Medical House PLC, Watson, Abbott, Eli Lilly, Auxillium, Inc., Endo Pharmaceuticals, Teva, Mylan, Roxane, Bedford Labs, APP Pharmaceuticals, Hospira, Pfizer, GSK/Astellas, Warner Chilcott and Allergan.

Advisors' Opinion:

• [By Keith Speights]

  Antares Pharma (NASDAQ: ATRS  ) announced its first-quarter results �Wednesday morning but failed to impress the market. Shares were down around 3% in midday trading. Here are the highlights from the company's results.

Top 5 Promising Stocks To Buy For 2014: Rockwood Holdings Inc (ROC)

Rockwood Holdings, Inc. (Rockwood), incorporated in September 19, 2000, is a developer, manufacturer and marketer of specialty chemicals and advanced materials used for industrial and commercial purposes. Rockwood is focused on surface treatment and lithium chemicals, advanced ceramics, titanium dioxide pigments, iron-oxide pigments, timber-treatment chemicals and clay-based additives. Its products consist primarily of inorganic chemicals and solutions and engineered materials. As of December 31, 2012, it manufactured its products in 80 facilities in more than twenty countries and sold its products and services to more than 60,000 customers. The Company operates in five segments: Lithium, Surface Treatment, Performance Additives, Titanium Dioxide Pigments, and Advanced Ceramics. In September 2012, its subsidiary, Chemetall GmbH, completed the formal legal split of its operations into two independent legal entities. In September 2013, Rockwood Holdings, Inc completed the sale of CeramTec, its advanced ceramics business to Cinven. In October 2013, Rockwood Holdings Inc announced that the specialty chemicals group ALTANA completed the acquisition of the rheology business of Rockwood Holdings, Inc.

Lithium

The Company�� Lithium segment operates under the Rockwood Lithium brand name and develops lithium chemicals for a range of industries and end markets. It develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties and reagents, including butyllithium and lithium aluminum hydride. The Company operates its lithium business along five business divisions: Lithium Salts, Special Salts, Butyllithium/Lithium Metal, Battery Products and Lithium Specialties.

The Company develops and manufactures basic lithium compounds, which serve a range of industries and applications, and potash. Its products include lithium carbonate, lithium hydroxide, lithium nitrate, lithium chloride ! and potash. The Company develops and manufactures products which include lithium phosphate, lithium bromide and lithium carbonate pharmaceutical grade. It develops and manufactures lithium products for electronic applications, mainly for the primary (disposable) and secondary (rechargeable) battery industries. It develop and manufacture lithium compounds and other products for life science applications, such as special reagents for the synthesis of drug intermediates as well as for the flavor and fragrances industry. The Company develops and manufactures a range of products based on special metal compounds derived from cesium, zirconium, titanium, barium and rubidium.

The Company competes with FMC Corporation, Sociedad Quimica y Minera de Chile S.A., Cabot Corporation, Sigma Aldrich Corporation.

Surface Treatment

The Company�� Surface Treatment segment operates under the Chemetall brand name and develops and manufactures metal surface treatment products and services for a range of industries and end markets. This segment supplies surface treatment products and solutions for metal processing industries. It develops and supplies products and solutions for the chemical pre-treatment of metals and other substrates, some of which are customized for individual customers and applications. The Company provides surface treatment products and solutions for automotive original equipment manufacturers (OEMs), including an entire range of products and services for use in the paint shop step of car-body and automotive component manufacture. It provides products and services used to facilitate the cold forming of tubes, wire drawing and cold extrusion of metal.

The Company competes with Henkel AG & Co. KGaA, Nihon Parkerizing Co., Ltd., PPG Industries, Inc. and Nippon Paint Co., Ltd.

Performance Additives

The Company�� Performance Additives segment consists of business lines which develop and manufacture a range of specialty chemicals us! ed indust! rial and consumer products and processes. The Company produces synthetic iron-oxide and other inorganic pigments in a range of yellow, red, orange, ultramarine blue, black, manganese violet or blended shades, and serves the construction, paints and coatings, plastics, and specialty application markets with powder, granular and liquid grades. The Company develops and manufactures principally iron-oxide pigments for manufacturers of construction products for use in the coloring of concrete products, including paving stones, bricks, concrete blocks, roofing tiles, stucco and mortar.

It also develops and manufactures color pigments for the paints, coatings, plastics, paper and rubber end-use markets including its brands Ferroxide, Trans-oxide, Solaplex, Solarox and Colourplex. It produces a wide variety of pigments that include synthetic iron-oxides, corrosion inhibitor pigments, complex inorganic color pigments and process natural pigments such as burnt umbers and siennas. Its iron-oxide pigments are also used in a variety of specialty applications such as toner for printers and copiers, security inks used to print bank notes, catalysts for styrene production and cosmetics.

The Company�� Timber Treatment Chemicals business line manufactures food protection products primarily in North America and Europe. Its Timber Treatment Chemicals business also manufactures inorganic chemicals such as nitrates and chlorides for various industrial applications including chemicals that are added to concrete as curing accelerants and corrosion inhibitors, chemicals that are used for odor control in water treatment, galvanizing fluxes, micronutrients, pesticides and catalysts used in the manufacture of textile resins. The Company also develops and manufacture inorganic metallic chemicals for certain specialty markets. Its Clay-based Additives business develops and manufactures a range of specialty rheology modifiers and additives.

The Company competes with Lanxess AG, Cathay Pigment! s Group, ! Interstar Materials Inc. and Shanghai Yipin Pigments Co., Ltd., Lonza Group Ltd, Osmose, Inc., BASF Group, Kurt Obermeier GmbH & Co. KG, Rutgers AG, Elementis plc, Laviosa Chimica Mineraria S.p.A., R.T. Vanderbilt Company, Inc., Amcol, and Feralco AB.

Titanium Dioxide Pigments

The Company�� Titanium Dioxide Pigments segment operates under the Sachtleben brand name. Titanium Dioxide Pigments consists of two business lines: Titanium Dioxide and Functional Additives. It produces specialty grade titanium dioxide (TiO2) serving a variety of customers in the synthetic fibers, plastics, paints, packaging inks, coatings, cosmetics, pharmaceuticals and paper industries. The Company also develops TiO2 pigments, which are mainly used in special applications such as selected coatings, paints, packaging inks, plastics and laminated paper production processes. Its Functional Additives business line is a global manufacturer of barium-based and zinc-based inorganic fine white pigments and additives.

The Company competes with Fuji Titanium Industry Co., Ltd, Kronos Worldwide, Inc, DuPont Titanium Technologies, Cristal Global, Tronox Incorporated, Huntsman LLC, Tayca Corporation, Ishihara Corporation and Evonik Degussa., Solvay S.A., Gruppo Chimico Dalton S.p.A., Sakai Chemical Industry Co., Ltd.

Advanced Ceramics

The Company�� Advanced Ceramics segment operates under the CeramTec brand name. The Company produces ceramic components for hip joint prostheses, such as ball heads and inserts and ceramic glove formers latex gloves. The Company develops and manufacture products used in cutting tools, other tools and tooling systems. The Company develops and manufactures ceramic components that are used in mechanical applications and systems. Its products in mechanical applications include cutting blades, drawing and forming tools, drawing cones and capstans, guide elements, precision parts, pre-forms and friction discs. It also produces products used for app! lications! in certain niche markets, such as electrical/thermal and ceramic metal connections, pre-forms for the casting process of piston engines, mainly for diesel engines, and wear and corrosion protection in industrial plants and armor components used in vehicle protection.

The Company competes with Kyocera Corporation, CoorsTek, Inc., The Morgan Crucible Company plc and 3M.

Advisors' Opinion:

• [By Jonas Elmerraji]

  We're seeing the exact same trading setup in shares of Rockwood Holdings (ROC) right now, only stretched out much longer term. ROC has actually spent most of 2013 stuck consolidating in an ascending triangle pattern of its own, with resistance in place at $68. Despite some attempts at pushing through that price level back in late September, ROC is still in the pattern.

  That makes $68 the price level to watch in November.

  The resistance level to watch now is at $36. A move through that price ceiling is the signal that buyers are in control of shares, and upside is a high-probability trade. Typically, rounding bottoms come into play at the bottom of a stock's recent price action, not the top (as in MSFT's case). But while this setup isn't textbook, the trading implications are every bit as bullish here.

  A move through $37.50 is a signal that it's time to be a buyer in Lions Gate, while a breakdown through $34 means that it's time to sell.

  Whenever you're looking at any technical price pattern, it's critical to think in terms of those buyers and sellers. Rectangles, triangles, and other pattern names are a good quick way to explain what's going on in a stock, but they're not the reason it's tradable – instead, it all comes down to supply and demand for shares.

  That $37.50 resistance level is a price where there has been an excess of supply of shares; in other words, it's a place where sellers have been more eager to step in and take gains than buyers have been to buy. That's what makes a breakout above it so significant -- the move means that buyers are finally strong enough to absorb all of the excess supply above that price level. Don't be early on this trade.

• [By Monica Gerson]

  Huntsman (NYSE: HUN) surged 8.05% to $20.68 in the pre-market session after the company announced its plans to buy Rockwood Holdings' (NYSE: ROC) Performance Additives and Titanium Dioxide businesses for $1.1 billion in cash.

Top 5 Promising Stocks To Buy For 2014: Mack-Cali Realty Corporation (CLI)

Mack-Cali Realty Corporation is a real estate investment trust (REIT). It engages in the leasing, management, acquisition, development, and construction of commercial real estate properties in the United States. The firm invests in the real estate markets of the United States primarily in the northeastern United States, as well as in the District of Columbia. It primarily invests in office and office/flex buildings, totaling approximately 30.0 million square feet, and developable land. The firm�s properties also include industrial/warehouse buildings, retail properties, a hotel, and parcels of land leased. Mack-Cali Realty was incorporated in 1994 and is based in Cranford, New Jersey.

Advisors' Opinion:

• [By GuruFocus]

  George Soros (Trades, Portfolio) just reported his first quarter portfolio. He buys Citrix Systems Inc, Baker Hughes Inc, Comcast Corp, Spansion Inc, etc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, Soros Fund Management LLC. As of 03/31/2014, Soros Fund Management LLC owns 305 stocks with a total value of $10.1 billion. These are the details of the buys and sells.New Purchases: BHI, CODE, CTRP, CLI, AVB, COMM, CNQ, AGO, AUY, ATML, ASH, BXMT, CSTM, AEM, CMA, ARE, CHKP, AUQ, BEAV, CX, ADSK, AALCP, BLK, AIG, BIIB, ADEP, AMRI, ARWR, ATHX, BALT, BCRX, BEAT, CFX, CLFD, CUR, CODE,Added Positions: CTXS, CMCSA, CNP, ALTR, BRCD, CBS, CRM, CHTR, CCJ, CIEN, BIDU, ALLE, ABT, CDNS, ACT,Reduced Positions: AAPL, CCI, AMT, ABBV, AAL, BITA, AL, ANGI, ARIA, CBST, BA, BIRT, EXAR,Sold Out: C, BAC, CRI, AMZN, AGN, CF, BRCM, COTY, BMY, AMCX, CAR, A, ADBE, AFL,For the details of George Soros (Trades, Portfolio)'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=George+SorosThis is the sector weightings of his portfolio:Technology18.9%Energy14%Healthcare8.3%Consumer Defensive8.2%Communication Services8.1%Consumer Cyclical5.4%Industrials5.1%Basic Materials4.9%Financial Services2.5%Real Estate1.9%Utilities0.5%These are the top 5 holdings of George Soros (Trades, Portfolio)1. Teva Pharmaceutical Industries Ltd (TEVA) - 10,310,041 shares, 5.4% of the total portfolio. Shares added by 10.67%2. Herbalife Ltd (HLF) - 4,901,337 shares, 2.8% of the total portfolio. Shares added by 52.9%3. EQT Corp (EQT) - 2,573,814 shares, 2.5% of the total portfolio. Shares added by 3.27%4. Adecoagro SA (AGRO) - 25,915,076 shares, 2.1% of the total portfolio.5. Halliburton Co (HAL) - 3,596,353 shares, 2.1% of the total portfolio. Shares reduced by 20.73%New Purchase: Baker Hughes Inc (BHI)George Soros (Trades, Portfolio) initiated holdings in Baker Hughes Inc. His purchase prices were between $51.82 and $65.27, with an estimated

• [By Dan Burrows]

  Mack-Cali Realty (CLI)

  CLI Price/LFCF: 6.5
  CLI Dividend Yield: 5.5%

  Real estate investment trusts are dividend stocks that tend to have firehoses of levered free cash. That’s because once a month, every month, the rent checks and get paid and those payments pile up.

• [By Lisa Levin]

  Mack-Cali Realty (NYSE: CLI) shares reached a new 52-week low of $19.12. Mack-Cali's PEG ratio is -2.63.

  Rocket Fuel (NASDAQ: FUEL) shares dipped 11.85% to touch a new 52-week low of $41.74 on Q3 results.

Top 5 Promising Stocks To Buy For 2014: Skilled Healthcare Group Inc.(SKH)

Skilled Healthcare Group, Inc., through its subsidiaries, operates skilled nursing facilities, assisted living facilities, hospices, home health providers, and a rehabilitation therapy business. Its skilled nursing facilities provide specialty care, such as chemotherapy, enteral/parenteral nutrition, tracheotomy care, and ventilator care, as well as offers various services, including room and board, special nutritional programs, social services, recreational activities, and related healthcare and other services. These skilled nursing facilities include Express Recovery, a unit that provides skilled nursing care and rehabilitation therapy for patients recovering from conditions, such as joint replacement surgery, and cardiac and respiratory ailments. The company?s assisted living facilities provide residential accommodations, activities, meals, security, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support , but not the level of nursing care provided in a skilled nursing facility. Skilled Healthcare Group also offers ancillary services, such as physical, occupational, and speech therapy, as well as rehabilitation therapy service to third-party skilled nursing operators. In addition, the company offers hospice services comprising palliative and clinical care, education, and counseling with a focus on the physical, spiritual, and psychosocial needs of terminally ill individuals and their families. As of December 31, 2010, it owned or leased 78 skilled nursing facilities and 22 assisted living facilities, together comprising 10,830 licensed beds in California, Texas, Iowa, Kansas, Missouri, Nevada, and New Mexico. The company has a joint venture with APS?Summit Care Pharmacy, LLC that operates a pharmacy in Austin, Texas. Skilled Healthcare Group, Inc. is based in Foothill Ranch, California.

Advisors' Opinion:

• [By Rich Smith]

  Foothill Ranch, Calif.-based Skilled Healthcare (NYSE: SKH  ) needs a new CEO.

  On Monday, the assisted living facilities operator announced that Chief Executive Officer Boyd Hendrickson plans to retire from the company at the end of this year. A search for a replacement is now under way.